Education

Masters of Science in Nursing (MSN) August 2012 - August 2013

Florida International University, Miami Florida

Bachelors of Science in Nursing (BSN), SUMMA CUM LAUDE August 2010 - August 2012

Florida International University, Miami Florida

Medical Doctor (MD), September 1989 - April 1996

University Central of Venezuela – Medical School “Luis Razetti”

Caracas, Venezuela

Certifications, Degrees and Licenses

Advanced Registered Nurse Practitioner Certification (ARNP, FNP-C) September 2013

Masters of Science in Nursing Degree August 2013

Bachelors of Science in Nursing Degree August 2012

Registered Nurse License July 31, 2012

License Number: ARNP 9346973 Expiration: April 30, 2018

Basic Life Support (BLS) Certification August 31, 2014

Physician Surgeon Degree April 1996

Awards and Honors

Graduated Summa Cum Laude from Florida International University

Member of Golden Key International Honor Society

Languages

English and Spanish language: Conversational and written proficiencies; entirely bilingual.

Strong knowledge of French: Conversational.

Employment History

Family Nurse Practitioner (Adult/Geriatrics) July 2017- Current date

Metro Health (Managed Care Practice)

Family Nurse Practitioner (Adult/Geriatrics) November 2013- June 2017

JSA Medical Group a division of DaVita HealthCare Partners (Managed Care Practice)

Clinical Research Coordinator May 2010 – November 2013

Department of Hepatology, Miami VA Medical Center

Professional Experience and Skills

• Proficient in sutures/skin laceration repairs, digital nerve block, minor wound care, incision and drainage of abscesses, epidermal inclusion cysts, pilonidal cysts, and skin punch biopsies.

• Proficient in standard palpation-guided steroid joint injection of knees, shoulders, hips as well as trigger point injections

• Proficient in other Clinic Procedures: Pap smears and pelvic examinations; Pessary removal, cleansing and reinsertion; EKG reading and interpretation

• Proficient in the use of electronic medical records (ECW), MRA/HCC

Different Clinical Trial Participation as Research Coordinator:

1.IDX-08C-004 "A Phase II, Randomized, Double-Blind Study to Evaluate the Safety and Antiviral Activity of IDX 184 in Combination with Pegylated Interferon And Ribavirin in Subjects with Genotype I Chronic Hepatitis C Infection

2.Randomized, Controlled Phase IIa/b Study of the Efficacy and Safety of PEG-rIL-29 Administered in Combination with Ribavirin to Treatment-Naïve Subjects with Chronic Hepatitis C Virus Infection.

3.A Dose-Ranging Study to Test the Safety, Tolerability, and Effectiveness of Different Doses of MK-5172 when given with PegIFN alfa-2b and Ribavirin in Patients with G1, HCV Infection.

4.Open-Label, Single Arm Evaluation of BMS-790052 in Combination with Peg-Interferon Alfa-2a and Ribavirin in Black-African Americans, Latinos, and White-Caucasians with Chronic Hepatitis C Genotype 1 Infection.

5.An Open-Label, Phase 4 Study of Telaprevir, Peginterferon Alfa-2a (Pegasys®), and Ribavirin (Copegus®) in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C Who Have Not Achieved a Sustained Viral Response With a Prior Course of Interferon-Based Therapy.

6.A phase 3, multi-center, randomized, open-label study, to investigate the efficacy and safety of sofosbuvir/GS-5885 fixed dose combination + Ribavirin for 12 and 24 weeks in treatment naïve subjects with chronic genotype 1 HCV infection.

References Available upon request

Contact this candidate